Silynxcom’s Backlog Surges Past 2025 Revenue Amid Global Tactical Headset Expansion

Citius Pharmaceuticals Leverages FDA-Approved LYMPHIR and Late-Stage Pipeline to Drive Growth

Climate Extremes Undermine Europe’s Clean Energy Efforts as Drought Halts Hungarian Nuclear Plant

Regentis Biomaterials Secures Japanese Patent for GelrinC Manufacturing, Boosting Commercialization Prospects

Greenland Mines Advances Western Critical Minerals Strategy Amid Supply Chain Concerns

SS Innovations Reports Record Q2 Revenue, Advances SSi Mantra Robotic Surgery Platform

Chinese EV Brands Gain Ground in Europe as Sales Surge

Regentis Biomaterials Advances GelrinC with Parallel U.S. Clinical and European Commercial Strategies

Perpetuals.com Gains EU-Wide Crypto License Under MiCA, Expanding Regulated Services

Regentis Biomaterials Expands Global IP Protection for GelrinC with Japanese Patent Allowance

Europe’s First Wave of EV Batteries Nearing End of Life Sparks Recycling Urgency

EU Offers €1.5 Billion in Interest-Free Loans to Boost EV Battery Production

EU Electric Vehicle Registrations Rise 5.7% in First Half of 2026, Contrasting US Stagnation

Fiber-Based Beverage Multipack Carriers Market Set to Reach $1.6 Billion by 2036 as Brands Ditch Plastic

Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology Targeting Neurodegenerative Diseases

Vehicle Batteries Could Help EU Overcome Grid Connection Delays for Renewables

Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology

REPLOID Group Spins Off Fertilizer Business into Dedicated Company REPLOID REGREEN GmbH

Regentis Biomaterials Gains European Approval for Next-GelrinC Manufacturing, Boosting Yield by 400%

Regentis Biomaterials Gains European Approval for Next-GelrinC Manufacturing, Boosting Yield by 400%